8-K
Current Report
Viridian Therapeutics, Inc.\DE Filed Acc 0001193125-24-164461
Executive or director change · Shareholder vote results
- Item 5.02 Departure or appointment of directors or officers
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading d857947d8k.htm…